Published in J Dermatol Sci on May 10, 2011
An overview of clinical and experimental treatment modalities for port wine stains. J Am Acad Dermatol (2012) 1.16
Endovascular laser–tissue interactions and biological responses in relation to endovenous laser therapy. Lasers Med Sci (2014) 0.96
An overview of three promising mechanical, optical, and biochemical engineering approaches to improve selective photothermolysis of refractory port wine stains. Ann Biomed Eng (2011) 0.93
Photocoagulation of dermal blood vessels with multiple laser pulses in an in vivo microvascular model. Lasers Surg Med (2012) 0.81
Review of the progress toward achieving heat confinement-the holy grail of photothermal therapy. J Biomed Opt (2017) 0.75
Tranexamic Acid-Encapsulating Thermosensitive Liposomes for Site-Specific Pharmaco-Laser Therapy of Port Wine Stains. J Biomed Nanotechnol (2016) 0.75
Decreased ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ failure. Crit Care Med (2007) 2.37
Redarkening of port-wine stains 10 years after pulsed-dye-laser treatment. N Engl J Med (2007) 1.92
Thrombotic thrombocytopenic purpura directly linked with ADAMTS13 inhibition in the baboon (Papio ursinus). Blood (2010) 1.75
Binding of von Willebrand factor to collagen and glycoprotein Ibalpha, but not to glycoprotein IIb/IIIa, contributes to ischemic stroke in mice--brief report. Arterioscler Thromb Vasc Biol (2010) 1.74
The role of renal hypoperfusion in development of renal microcirculatory dysfunction in endotoxemic rats. Intensive Care Med (2011) 1.72
Endovenous laser ablation: a review of mechanisms of action. Ann Vasc Surg (2012) 1.68
Matrix-specific suppression of integrin activation in shear stress signaling. Mol Biol Cell (2006) 1.67
Deficiency of von Willebrand factor protects mice from ischemic stroke. Blood (2009) 1.65
Blood transfusions recruit the microcirculation during cardiac surgery. Transfusion (2010) 1.62
Balanced vs unbalanced crystalloid resuscitation in a near-fatal model of hemorrhagic shock and the effects on renal oxygenation, oxidative stress, and inflammation. Resuscitation (2011) 1.59
Microvascular and interstitial oxygen tension in the renal cortex and medulla studied in a 4-h rat model of LPS-induced endotoxemia. Shock (2011) 1.52
Functional genomics in zebrafish permits rapid characterization of novel platelet membrane proteins. Blood (2008) 1.45
Platelet microparticle formation and thrombin generation under high shear are effectively suppressed by a monoclonal antibody against GPIba. Thromb Haemost (2006) 1.43
Formation of fibrosis after nonablative and ablative fractional laser therapy. Dermatol Surg (2011) 1.41
Platelets at work in primary hemostasis. Blood Rev (2011) 1.34
Shielding of the A1 domain by the D'D3 domains of von Willebrand factor modulates its interaction with platelet glycoprotein Ib-IX-V. J Biol Chem (2005) 1.34
Bacillus anthracis oedema toxin as a cause of tissue necrosis and cell type-specific cytotoxicity. Cell Microbiol (2005) 1.25
Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood. Blood (2003) 1.18
Transcription profiling in human platelets reveals LRRFIP1 as a novel protein regulating platelet function. Blood (2010) 1.16
von Willebrand factor to the rescue. Blood (2009) 1.13
Correction of ear malformations by laser-assisted cartilage reshaping (LACR). Lasers Surg Med (2006) 1.12
Clinical review: Clinical imaging of the sublingual microcirculation in the critically ill--where do we stand? Crit Care (2012) 1.11
Mitochondrial PO2 measured by delayed fluorescence of endogenous protoporphyrin IX. Nat Methods (2006) 1.07
Platelet adhesion to collagen. Thromb Res (2011) 1.04
Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand disease. Arterioscler Thromb Vasc Biol (2008) 1.02
Laboratory diagnosis and molecular classification of von Willebrand disease. Acta Haematol (2009) 1.01
Role of glycoprotein Ibalpha in phagocytosis of platelets by macrophages. Transfusion (2006) 1.01
ADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosis. Br J Haematol (2007) 1.01
Key role of glycoprotein Ib/V/IX and von Willebrand factor in platelet activation-dependent fibrin formation at low shear flow. Blood (2010) 1.00
Identification of residues within human glycoprotein VI involved in the binding to collagen: evidence for the existence of distinct binding sites. J Biol Chem (2004) 1.00
In vivo mitochondrial oxygen tension measured by a delayed fluorescence lifetime technique. Biophys J (2008) 1.00
Mitochondrial oxygen tension within the heart. J Mol Cell Cardiol (2009) 1.00
Phenotypic correction of von Willebrand disease type 3 blood-derived endothelial cells with lentiviral vectors expressing von Willebrand factor. Blood (2006) 0.99
Synergistic effect of thrombin on collagen-induced platelet procoagulant activity is mediated through protease-activated receptor-1. Arterioscler Thromb Vasc Biol (2005) 0.99
Rational humanization of the powerful antithrombotic anti-GPIbalpha antibody: 6B4. Thromb Haemost (2006) 0.98
Antiplatelet drugs. Br J Haematol (2008) 0.98
L-NIL prevents renal microvascular hypoxia and increase of renal oxygen consumption after ischemia-reperfusion in rats. Am J Physiol Renal Physiol (2009) 0.98
Principal role of glycoprotein VI in alpha2beta1 and alphaIIbbeta3 activation during collagen-induced thrombus formation. Arterioscler Thromb Vasc Biol (2004) 0.97
Noninvasive cardiac output monitoring during exercise testing: Nexfin pulse contour analysis compared to an inert gas rebreathing method and respired gas analysis. J Clin Monit Comput (2011) 0.97
Inherited traits affecting platelet function. Blood Rev (2008) 0.97
Towards optimization of selective photothermolysis: prothrombotic pharmaceutical agents as potential adjuvants in laser treatment of port wine stains. A theoretical study. Thromb Haemost (2005) 0.96
Model systems of genetically modified platelets. Blood (2011) 0.96
Red blood cell transfusions and tissue oxygenation in anemic hematology outpatients. Transfusion (2011) 0.96
Activation of alphaIIbbeta3 is a sufficient but also an imperative prerequisite for activation of alpha2beta1 on platelets. Blood (2006) 0.95
An overview of three promising mechanical, optical, and biochemical engineering approaches to improve selective photothermolysis of refractory port wine stains. Ann Biomed Eng (2011) 0.93
Decreased glycogen synthase kinase 3-beta levels and related physiological changes in Bacillus anthracis lethal toxin-treated macrophages. Cell Microbiol (2003) 0.92
Multi-site and multi-depth near-infrared spectroscopy in a model of simulated (central) hypovolemia: lower body negative pressure. Intensive Care Med (2011) 0.92
Recombinant activated protein C treatment improves tissue perfusion and oxygenation in septic patients measured by near-infrared spectroscopy. Crit Care (2009) 0.91
Photodynamic therapy of malignant brain tumours: a complementary approach to conventional therapies. Cancer Treat Rev (2012) 0.91
Monoclonal antibody IAC-1 is specific for activated alpha2beta1 and binds to amino acids 199 to 201 of the integrin alpha2 I-domain. Blood (2004) 0.91
Nonablative 1550-nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled pilot study. J Am Acad Dermatol (2011) 0.90
The humanized anti-glycoprotein Ib monoclonal antibody h6B4-Fab is a potent and safe antithrombotic in a high shear arterial thrombosis model in baboons. Thromb Haemost (2008) 0.89
Blood platelet biochemistry. Thromb Res (2011) 0.89
Two functional active conformations of the integrin {alpha}2{beta}1, depending on activation condition and cell type. J Biol Chem (2005) 0.89
Von Willebrand factor: drug and drug target. Cardiovasc Hematol Disord Drug Targets (2009) 0.89
Shear-dependent morphology of von Willebrand factor bound to immobilized collagen. Blood (2002) 0.87
Inhibition of platelet glycoprotein Ib and its antithrombotic potential. Curr Pharm Des (2007) 0.87
The acute effects of acetate-balanced colloid and crystalloid resuscitation on renal oxygenation in a rat model of hemorrhagic shock. Resuscitation (2012) 0.87
Modeling acardiac twin pregnancies. Ann N Y Acad Sci (2007) 0.87
Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques. Thromb Haemost (2007) 0.87
Cryoablation induces greater inflammatory and coagulative responses than radiofrequency ablation or laser induced thermotherapy in a rat liver model. Surgery (2009) 0.87
Commonly used fiber tips in endovenous laser ablation (EVLA): an analysis of technical differences. Lasers Med Sci (2013) 0.86
Improved platelet survival after cold storage by prevention of glycoprotein Ibα clustering in lipid rafts. Haematologica (2012) 0.86
Inhibition of platelet glycoprotein Ib, glycoprotein IIb/IIIa, or both by monoclonal antibodies prevents arterial thrombosis in baboons. Arterioscler Thromb Vasc Biol (2002) 0.86
New insights into von Willebrand disease and platelet function. Semin Thromb Hemost (2012) 0.86
A consensus tetrapeptide selected by phage display adopts the conformation of a dominant discontinuous epitope of a monoclonal anti-VWF antibody that inhibits the von Willebrand factor-collagen interaction. J Biol Chem (2003) 0.86
Focal laser ablation of prostate cancer: numerical simulation of temperature and damage distribution. Biomed Eng Online (2011) 0.86
Cholestasis is associated with hepatic microvascular dysfunction and aberrant energy metabolism before and during ischemia-reperfusion. Antioxid Redox Signal (2012) 0.86
New model of transient strain-dependent autoimmune thrombocytopenia in mice immunized with rat platelets. Exp Hematol (2004) 0.85
Patient autoantibodies induce platelet destruction signals via raft-associated glycoprotein Ibα and Fc RIIa in immune thrombocytopenia. Haematologica (2013) 0.85
Platelet physiology and antiplatelet agents. Clin Chem Lab Med (2010) 0.85
Improvement of sidestream dark field imaging with an image acquisition stabilizer. BMC Med Imaging (2010) 0.85
Scar prevention by laser-assisted scar healing (LASH): a pilot study using an 810-nm diode-laser system. Lasers Surg Med (2008) 0.85
Experimental indication for the existence of multiple Trp rotamers in von Willebrand Factor A3 domain. Proteins (2004) 0.84
The control of dendritic cell maturation by pH-sensitive polyion complex micelles. Biomaterials (2008) 0.84
Near infrared spectroscopy. Crit Care Med (2009) 0.84
Local elongation of endothelial cell-anchored von Willebrand factor strings precedes ADAMTS13 protein-mediated proteolysis. J Biol Chem (2011) 0.84
von Willebrand factor but not alpha-thrombin binding to platelet glycoprotein Ibalpha is influenced by the HPA-2 polymorphism. Arterioscler Thromb Vasc Biol (2003) 0.83
The microcirculatory response to compensated hypovolemia in a lower body negative pressure model. Microvasc Res (2011) 0.83
Investigation of the interface in silica-encapsulated liposomes by combining solid state NMR and first principles calculations. J Am Chem Soc (2011) 0.83
Acute effects of balanced versus unbalanced colloid resuscitation on renal macrocirculatory and microcirculatory perfusion during endotoxemic shock. Shock (2012) 0.83
Peripheral perfusion index as an early predictor for central hypovolemia in awake healthy volunteers. Anesth Analg (2013) 0.82
Non-ablative 1,550 nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled split-face study. Lasers Surg Med (2010) 0.82
The novel S527F mutation in the integrin beta3 chain induces a high affinity alphaIIbbeta3 receptor by hindering adoption of the bent conformation. J Biol Chem (2009) 0.82
Suture-free laser-assisted vessel repair using CO2 laser and liquid albumin solder. J Biomed Opt (2008) 0.82
Non-ablative 1550 nm fractional laser therapy not effective for erythema dyschromicum perstans and postinflammatory hyperpigmentation: a pilot study. J Dermatolog Treat (2011) 0.82
Paratope and epitope mapping of the antithrombotic antibody 6B4 in complex with platelet glycoprotein Ibalpha. J Biol Chem (2007) 0.82
Red blood cell storage increases hypoxia-induced nitric oxide bioavailability and methemoglobin formation in vitro and in vivo. Transfusion (2014) 0.82
Treatment effects of combined radio-frequency current and a 900 nm diode laser on leg blood vessels. Lasers Surg Med (2006) 0.82
1.9 µm diode laser assisted vascular microanastomoses: Experience in 40 clinical procedures. Lasers Surg Med (2011) 0.82
Outcomes after 1.9-microm diode laser-assisted anastomosis in reconstructive microsurgery: results in 27 patients. Plast Reconstr Surg (2010) 0.82
The A/T1381 polymorphism in the A1-domain of von Willebrand factor influences the affinity of von Willebrand factor for platelet glycoprotein Ibalpha. Thromb Haemost (2007) 0.81
Transfusion of banked red blood cells and the effects on hemorrheology and microvascular hemodynamics in anemic hematology outpatients. Transfusion (2012) 0.81
Paratope determination of the antithrombotic antibody 82D6A3 based on the crystal structure of its complex with the von Willebrand factor A3-domain. J Biol Chem (2005) 0.81
Blood flow assessment with magnetic resonance imaging after 1.9 microm diode laser-assisted microvascular anastomosis. Lasers Surg Med (2010) 0.81